Protein nitration increased by simulated weightlessness and decreased by melatonin and quercetin in PC12 cells.
A variety of experiments suggest that space flight is associated with an increase in oxidative stress in organism. To explore the effects of oxidative stress on neuronal cells during microgravity, we used rat pheochromocytoma (PC12) cells as a neuronal cell model, cultured in a clinostat, which could simulate microgravity, to investigate the effects of reactive nitrogen species on protein nitration in PC12 cells during clinorotation. The effects of melatonin and quercetin on protein nitration in PC12 cells were also assayed to evaluate the possible protective role of melatonin or quercetin as an antioxidant. The results of immunological staining showed that after the 3 days' clinorotation the protein expressions of neuronal nitric oxide synthase and inducible nitric oxide synthesis were up-regulated. Our data also reflected that the concentrations of nitric oxide and nitrotyrosine were significantly increased after clinorotation, and they were reduced markedly in cells that were treated with 50 micromol/L melatonin or 0.5 micromol/L quercetin during simulated microgravity, when compared to those of control cells. These results suggest that clinorotation-induced weightlessness increases oxidative stress responses in PC12 cells, and melatonin or quercetin was shown to protect PC12 cells from oxidative damage during simulated weightlessness.
Qu
Lina
L
Department of Space Cellular and Molecular Biology, Institute of Space Medico-Engineering, Beijing 100094, PR China. linaqu@263.net
Yang
Tangbin
T
Yuan
Yanhong
Y
Zhong
Ping
P
Li
Yinghui
Y
D000818:Animals; D008550:Melatonin / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D018384:Oxidative Stress; D016716:PC12 Cells; D011794:Quercetin / Q000494:pharmacology*; D051381:Rats; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000378:metabolism; D018474:Weightlessness Simulation / Q000009:adverse effects*
D009569:Nitric Oxide; C002744:3-nitrotyrosine; D014443:Tyrosine; D011794:Quercetin; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D008550:Melatonin